Data / Form D filings / TALPHERA, INC.
TALPHERA, INC.: Form D filings
TALPHERA, INC., a pharmaceuticals company in San Mateo, CA, filed 10 Form D notices with the SEC between 2009 and 2025. The latest, on September 15, 2025, reports $17 million sold of a $29 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1850 GATEWAY DRIVE, SUITE 175, San Mateo, CA, 94404
- Phone
- (650) 216-3500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1427925
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 15, 2025 | New notice | $28,969,997 | $16,984,999 | $11,984,998 | 13 | Sep 10, 2025 | sec.gov |
| Apr 17, 2025 | New notice | $15,000,000 | $4,920,000 | $10,080,000 | 11 | Apr 2, 2025 | sec.gov |
| Jan 29, 2024 | New notice | $6,000,000 | $6,000,000 | 6 | Jan 22, 2024 | sec.gov | |
| Jul 28, 2023 | New notice | $10,000,008 | $10,000,008 | 10 | Jul 17, 2023 | sec.gov | |
| Aug 17, 2022 | New notice | $629,958 | $629,958 | 1 | Aug 3, 2022 | sec.gov | |
| Jan 24, 2022 | New notice | $5,960,979 | $5,160,997 | $799,982 | 32 | Jan 7, 2022 | sec.gov |
| Jun 7, 2012 | New notice | $10,000,002 | $10,000,002 | 10 | Jun 1, 2012 | sec.gov | |
| Jul 13, 2011 | New notice | $20,839,994 | $20,839,994 | 2 | Jun 29, 2011 | sec.gov | |
| Sep 21, 2010 | New notice | $12,001,200 | $8,000,800 | $4,000,400 | 8 | Sep 14, 2010 | sec.gov |
| Nov 25, 2009 | New notice | $30,000,000 | $14,814,106 | $15,185,894 | 8 | Nov 23, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Adrian P Adams | Director | |
| Shakil P Aslam | Executive Officer | |
| Abhinav J Jain | Director | |
| Vincent J Angotti | Executive Officer, Director | |
| Marina P Bozilenko | Director | |
| Raffi P Asadorian | Executive Officer | |
| Mark J Wan | Director | |
| Jill P Broadfoot | Director | |
| Stephen J Hoffman | Director | |
| Badri P Dasu | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 15, 2025 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TALPHERA, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.